“Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation: Inflammatory marker elevation in MDS”, Mediterr J Hematol Infect Dis, vol. 15, no. 1, p. e2023044, Jun. 2023, doi: 10.4084/MJHID.2023.044.